Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 ,inter alia, to consider and approve Board Meeting on 6 August 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd (Scrip Code: 524322) has informed BSE that its Board of Directors will meet on 6 August 2025 at the company's corporate office. The key agenda items include discussing expansion plans and exploring new business opportunities, and broadening the board by inducting new technical people. The notice also includes a standard provision for any other matters with the chair's approval. No financial results or specific decisions have been disclosed yet — this is only an advance intimation of the meeting.
The agenda hints at potential growth direction and leadership changes, which could be positive if concrete expansion plans are announced, but until the meeting outcomes are disclosed, there is no direct impact on shareholders or the stock price.